UBS Group’s MKAM ETF MKAM Stock Holding History

UBS Group’s Portfolio MKAM Stock Details MKAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,063	Closed	-$62.9K	–	10927
2025 Q3	$62.9K	Sell	2,063 -15	-0.7%	-$449	﹤0.01%	7410
2025 Q2	$60.9K	Sell	2,078 -878	-30%	-$25.2K	﹤0.01%	7612
2025 Q1	$85.3K	Buy	2,956 +2,300	+351%	+$67.5K	﹤0.01%	7167
2024 Q4	$19.2K	Sell	656 -1	-0.2%	-$29	﹤0.01%	7901
2024 Q3	$19.1K	Buy	657 +322	+96%	+$9.2K	﹤0.01%	7405
2024 Q2	$9.53K	Buy	335 +302	+915%	+$8.41K	﹤0.01%	7741
2024 Q1	$918	Buy	+33	New	+$895	﹤0.01%	8306

Other funds holding MKAM

Evoke Wealth Los Angeles, California $1.56M AUM 25.68% 1-Year Est. Return

GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group's MKAM Position: Q4 2025 in Review

UBS Group sold out of MKAM ETF (MKAM) in Q4 2025, closing a stake of 2,063 shares — an estimated $62.9K sold.

UBS Group first reported a position in MKAM in Q1 2024 and held it in 7 quarters. The position peaked at $85.3K in Q1 2025. 3 funds tracked by Wall St. Rank hold MKAM as of Q4 2025.

UBS Group reported no remaining MKAM ETF position as of Q4 2025 after selling out during the quarter.
UBS Group sold 2,063 MKAM ETF shares in Q4 2025, an estimated $62.9K.
UBS Group first reported a position in MKAM ETF in Q1 2024 and held it in 7 quarters.
UBS Group's MKAM ETF position peaked at $85.3K in Q1 2025.
3 funds tracked by Wall St. Rank held MKAM ETF as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.